News & Events

AAPharmaSyn and AnchorBio have joined forces to deliver superior drug discovery and development services, including activity screening, medicinal chemistry, structure-activity relationship (SAR) analysis, lead optimization, synthesis of validated hits, and high-throughput screening (HTS) triage. All of which are crucial for efficient progression toward lead compound identification. 

This strategic collaboration combines AAPharmaSyn’s chemistry prowess with AnchorBio’s biological expertise. The partnership aims to offer unparalleled support to early-stage pharmaceutical companies while reducing the administrative overhead by providing a fully integrated approach to projects requiring close collaboration between biological analysis and synthetic chemistry. Clients can now benefit from a seamless integration of services that maximizes the strengths of both partners. 

 

AnchorBio Solutions provides a diverse set of high value biology-focused preclinical drug discovery services to accelerate pharma/biotech R&D and diagnostics discovery and development. Services provided include target discovery and validation, screening and profiling, biomarker discovery and development, and sample analysis and testing with scalable capabilities and workflows.

 

AAPharmaSyn offers a broad range of chemistry services to global and regional pharmaceutical and biotechnology clients. Services include custom synthesis, route scouting, lead optimization, process research and development, inventory management as well as procurement and distribution of high-value specialty chemicals. www.aapharmasyn.com